Ashton Hale
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Ashton Hale's research focuses on the discovery of novel therapeutic agents. Their recent publication details the identification of quinazoline-based compounds designed as dual inhibitors for RET and Aurora B kinases. This work is aimed at developing new treatments for non-small cell lung cancer, investigating specific molecular targets within cancer cells to impede tumor growth and progression.
Metrics
- Publications: 1
Selected Publications
-
Discovery of quinazoline-based dual RET/Aurora B inhibitors for non-small cell lung cancer (2026)
Collaboration Network
Top Collaborators
- Discovery of quinazoline-based dual RET/Aurora B inhibitors for non-small cell lung cancer
- Discovery of quinazoline-based dual RET/Aurora B inhibitors for non-small cell lung cancer
- Discovery of quinazoline-based dual RET/Aurora B inhibitors for non-small cell lung cancer
- Discovery of quinazoline-based dual RET/Aurora B inhibitors for non-small cell lung cancer
- Discovery of quinazoline-based dual RET/Aurora B inhibitors for non-small cell lung cancer
- Discovery of quinazoline-based dual RET/Aurora B inhibitors for non-small cell lung cancer
- Discovery of quinazoline-based dual RET/Aurora B inhibitors for non-small cell lung cancer
- Discovery of quinazoline-based dual RET/Aurora B inhibitors for non-small cell lung cancer
- Discovery of quinazoline-based dual RET/Aurora B inhibitors for non-small cell lung cancer
- Discovery of quinazoline-based dual RET/Aurora B inhibitors for non-small cell lung cancer
Similar Researchers
Based on overlapping research topics